Evren U Azeloglu, PhD
img_Evren U Azeloglu
ASSOCIATE PROFESSOR | Medicine, Nephrology
ASSOCIATE PROFESSOR | Pharmacological Sciences
Research Topics
Biomechanics/Bioengineering, Biophysics, Cardiovascular, Computational Biology, Cytoskeleton, Kidney, Mathematical Modeling of Biomedical Systems, Mathematical and Computational Biology, Nanotechnology, Signal Transduction, Systems Biology, Tissue Engineering
Our main goal at the Systems Bioengineering Lab is to understand mechanobiological decision-making capabilities and to develop novel therapeutics for precision medicine. We employ multiscale experimental and computational techniques as well as microfabrication and tissue engineering methods to study cell signaling, biomechanics, tissue function and regeneration using human induced pluripotent stem cell-derived cardiovascular and renal model systems. We also use multi-platform omics technologies and network analyses for identification of key information processing hubs and regulatory motifs that can be used as therapeutic targets in drug development for complex diseases such as hypertension, diabetic nephropathy and heart failure. See Azeloglu Lab website for more details.

BE, Stony Brook University

MS, Stony Brook University

PhD, Columbia University


NephCure Kidney International ASN Foundation Kidney Research Award

American Society of Nephrology


Howard Hughes Medical Institute Fellowship

Life Science Research Foundation


Yuen-huo Hung & Chao-chin Huang Award (2009)

Columbia University


Stony Wold Herbert Fellowship


Selected Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Azeloglu during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Access for Life
  • RenalytixAI

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.